# Natera, Inc.
> Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in genetic testing for prenatal health, oncology, and organ health. The company utilizes proprietary molecular biology and bioinformatics to provide non-invasive insights into human health and disease management.
- URL: https://optimly.ai/brand/natera
- Slug: natera
- BAI Score: 88/100
- Archetype: Challenger
- Category: Biotechnology / Healthcare
- Last Analyzed: April 10, 2026
- Part of: Independent Publicly Traded (https://optimly.ai/brand/independent-publicly-traded)
## Competitors
- Guardant Health (https://optimly.ai/brand/guardant-health)
## Also Referenced By
- Ambry Genetics (https://optimly.ai/brand/ambry-genetics)
- Invitae (https://optimly.ai/brand/invitae)
- Invitae Invitae (https://optimly.ai/brand/invitae-invitae)
- Adaptive Biotechnologies (https://optimly.ai/brand/adaptive-biotechnologies)
- Myriad Genetics, Inc. (https://optimly.ai/brand/myriad-genetics)
- Integrated Genetics (https://optimly.ai/brand/labcorp-integrated-genetics)
## Buyer Intent Signals
Problems: Standard OB/GYN Care: Standard prenatal care through obstetricians without genetic screening support. | Invasive Diagnostic Procedures: Invasive diagnostic procedures like Amniocentesis or Chorionic Villus Sampling (CVS).
Solutions: non-invasive prenatal testing providers | MRD testing for colorectal cancer | personalized liquid biopsy oncology | SNP-based genetic screening | kidney transplant rejection blood test | Hospital Labs: Hospital-based pathology and localized oncology screening services.
---
## Full Details / RAG Data
### Overview
Natera, Inc. is listed in the AI Directory.
Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in genetic testing for prenatal health, oncology, and organ health. The company utilizes proprietary molecular biology and bioinformatics to provide non-invasive insights into human health and disease management.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Natera, Inc. |
| Slug         | natera |
| URL          | https://optimly.ai/brand/natera |
| BAI Score    | 88/100 |
| Archetype    | Challenger |
| Category     | Biotechnology / Healthcare |
| Last Analyzed | April 10, 2026 |
| Last Updated | 2026-04-25T12:18:29.614Z |
### Verified Facts
- Founded: 2004
- Headquarters: Austin, Texas, USA
### Competitors
| Name | Profile |
|------|---------|
| Guardant Health | https://optimly.ai/brand/guardant-health |
### Also Referenced By
- Ambry Genetics (https://optimly.ai/brand/ambry-genetics)
- Invitae (https://optimly.ai/brand/invitae)
- Invitae Invitae (https://optimly.ai/brand/invitae-invitae)
- Adaptive Biotechnologies (https://optimly.ai/brand/adaptive-biotechnologies)
- Myriad Genetics, Inc. (https://optimly.ai/brand/myriad-genetics)
- Integrated Genetics (https://optimly.ai/brand/labcorp-integrated-genetics)
### Buyer Intent Signals
#### Problems this brand solves
- Standard OB/GYN Care: Standard prenatal care through obstetricians without genetic screening support.
- Invasive Diagnostic Procedures: Invasive diagnostic procedures like Amniocentesis or Chorionic Villus Sampling (CVS).
#### Buyers search for
- non-invasive prenatal testing providers
- MRD testing for colorectal cancer
- personalized liquid biopsy oncology
- SNP-based genetic screening
- kidney transplant rejection blood test
- Hospital Labs: Hospital-based pathology and localized oncology screening services.
### Parent Brand
- Independent Publicly Traded (https://optimly.ai/brand/independent-publicly-traded)
### Links
- Canonical page: https://optimly.ai/brand/natera
- JSON endpoint: /brand/natera.json
- LLMs.txt: /brand/natera/llms.txt